These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2929445)
1. When is QT prolongation antiarrhythmic and when is it proarrhythmic? Singh BN Am J Cardiol; 1989 Apr; 63(12):867-9. PubMed ID: 2929445 [No Abstract] [Full Text] [Related]
2. Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients. McCauley M; Vallabhajosyula S; Darbar D Card Electrophysiol Clin; 2016 Jun; 8(2):481-93. PubMed ID: 27261836 [TBL] [Abstract][Full Text] [Related]
3. [Cardiac side effects of anti-arrhythmia agents]. Seipel L Z Kardiol; 1988 Feb; 77(2):77-88. PubMed ID: 3284219 [TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic agents and the danger of proarrhythmic events. Josephson ME Ann Intern Med; 1989 Jul; 111(2):101-3. PubMed ID: 2662846 [No Abstract] [Full Text] [Related]
6. [Ventricular arrhythmias: diagnosis and drug therapy]. Schüpfer C; Gertsch M Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556 [TBL] [Abstract][Full Text] [Related]
7. A class III antiarrhythmic agent. Pelter MM; Adams MG Am J Crit Care; 2002 Jul; 11(4):395-6. PubMed ID: 12102441 [No Abstract] [Full Text] [Related]
8. Role of the electrocardiogram in determining electrophysiologic end points of drug therapy. Roden DM Am J Cardiol; 1988 Oct; 62(12):34H-38H. PubMed ID: 3052007 [TBL] [Abstract][Full Text] [Related]
12. The case for inpatient initiation of antiarrhythmic therapy. Myerburg RJ; Kloosterman M; Yamamura K; Mitrani R; Interian A; Castellanos A J Cardiovasc Electrophysiol; 1999 Mar; 10(3):482-7. PubMed ID: 10210516 [No Abstract] [Full Text] [Related]
13. [Proarrhythmic effects of anti-arrhythmia agents]. Enrico JF; Kehtari R Rev Med Suisse Romande; 1998 Aug; 118(8):671-90. PubMed ID: 9838826 [No Abstract] [Full Text] [Related]
14. [The principles of pharmacotherapy for arrhythmia at the turn of the millenium]. Fazekas T; Liszkai G Orv Hetil; 1999 Dec; 140(51):2851-9. PubMed ID: 10647274 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of arrhythmias: enhanced automaticity and reentry. Weller DM; Noone J Crit Care Nurse; 1989 May; 9(5):42-67. PubMed ID: 2680278 [TBL] [Abstract][Full Text] [Related]
16. Drug-induced proarrhythmic effects: assessment of changes in QT interval. Sheridan DJ Br J Clin Pharmacol; 2000 Oct; 50(4):297-302. PubMed ID: 11012551 [No Abstract] [Full Text] [Related]
17. Short QT syndrome review. Van Houzen NE; Alsheikh-Ali AA; Garlitski AC; Homoud MK; Weinstock J; Link MS; Estes NA J Interv Card Electrophysiol; 2008 Oct; 23(1):1-5. PubMed ID: 18299973 [No Abstract] [Full Text] [Related]
18. [Study on the assessment of antiarrhythmic drug efficacy by Holter electrocardiography (author's transl)]. Suzuki Y; Ishizaka K; Kobayashi A; Kamikawa T; Hayashi H; Masumura Y; Yamazaki N Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):421-30. PubMed ID: 7108327 [No Abstract] [Full Text] [Related]
19. Acceptable methods for titrating the dose of antiarrhythmic agents. Duff HJ Can J Cardiol; 1991 Mar; 7(2):98-100; discussion 103-4. PubMed ID: 2049690 [No Abstract] [Full Text] [Related]
20. [Antiarrhythmic drugs--differences between laboratory and clinical effects]. Harumi K Kokyu To Junkan; 1984 Dec; 32(12):1225-33. PubMed ID: 6396782 [No Abstract] [Full Text] [Related] [Next] [New Search]